Related Experiment Video
Updated: Feb 7, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim1, Razvan Cristescu2, Adam J Bass3
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifying determinants of response, we performed molecular characterization of tissues and circulating tumor DNA (ctDNA) from 61 patients with mGC who were treated with pembrolizumab as salvage treatment in a prospective phase 2 clinical trial. In patients with microsatellite instability-high and Epstein-Barr virus-positive tumors, which are mutually exclusive, dramatic responses to pembrolizumab were observed (overall response rate (ORR) 85.7% in microsatellite instability-high mGC and ORR 100% in Epstein-Barr virus-positive mGC). For the 55 patients for whom programmed death-ligand 1 (PD-L1) combined positive score positivity was available (combined positive score cut-off value ≥1%), ORR was significantly higher in PD-L1(+) gastric cancer when compared to PD-L1(-) tumors (50.0% versus 0.0%, P value <0.001). Changes in ctDNA levels at six weeks post-treatment predicted response and progression-free survival, and decreased ctDNA was associated with improved outcomes. Our findings provide insight into the molecular features associated with response to pembrolizumab in patients with mGC and provide biomarkers potentially relevant for the selection of patients who may derive greater benefit from PD-1 inhibition.
Insights
Pembrolizumab shows efficacy in metastatic gastric cancer (mGC). Molecular markers like microsatellite instability-high, Epstein-Barr virus positivity, and PD-L1 expression predict response, with ctDNA changes indicating outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Molecular Diagnostics
Background:
- Programmed cell death 1 (PD-1) inhibitors demonstrate efficacy in a subset of metastatic gastric cancer (mGC) patients.
- Identifying molecular determinants of response is crucial for optimizing PD-1 targeted therapy.
Purpose of the Study:
- To identify molecular features associated with response to pembrolizumab in mGC.
- To evaluate circulating tumor DNA (ctDNA) as a predictive biomarker for treatment response and survival.
Main Methods:
- Molecular characterization of tumor tissues and ctDNA from 61 mGC patients treated with pembrolizumab.
- Analysis of microsatellite instability (MSI), Epstein-Barr virus (EBV) status, and programmed death-ligand 1 (PD-L1) expression.
- Correlation of ctDNA dynamics with treatment response and progression-free survival.
Main Results:
- High response rates observed in MSI-high (85.7%) and EBV-positive (100%) mGC.
- Significantly higher overall response rate (ORR) in PD-L1 positive (50.0%) versus PD-L1 negative (0.0%) tumors (P<0.001).
- Decreased ctDNA levels post-treatment predicted improved outcomes and progression-free survival.
Conclusions:
- MSI-high, EBV-positive, and PD-L1 positive tumors are associated with favorable responses to pembrolizumab in mGC.
- ctDNA changes serve as a promising biomarker for predicting treatment response and survival in mGC patients.
- These findings offer insights for patient selection to maximize benefit from PD-1 inhibition in mGC.
More Related Videos
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Related Concept Videos
Feedback Inhibition
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Gastric Emptying
Molecular Orbital Theory II
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...